PRESS RELEASE published on 01/21/2025 at 14:01, 1 year ago Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population Mainz Biomed initiates U.S. clinical study to evaluate next-generation CRC test on advanced adenomas over large patient population. Study targets topline results by Q4 2025, focusing on biomarkers and AI algorithm Clinical Study Mainz Biomed CRC Screening Next Generation Test Advanced Adenomas
BRIEF published on 12/19/2024 at 14:05, 1 year 1 month ago Mainz Biomed s'associe à Quest Diagnostics pour un essai de dépistage du cancer Essais Cliniques Cancer Colorectal Approbation De La FDA Partenariat En Matière De Santé Services De Diagnostic
BRIEF published on 12/19/2024 at 14:05, 1 year 1 month ago Mainz Biomed Partners with Quest Diagnostics for Cancer Screening Trial FDA Approval Clinical Trials Colorectal Cancer Diagnostic Services Healthcare Partnership
PRESS RELEASE published on 12/19/2024 at 14:00, 1 year 1 month ago Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test Mainz Biomed forms agreement with Quest Diagnostics to provide clinical trials lab services for colorectal cancer screening test, enhancing early cancer detection efforts Clinical Trials Early Detection Mainz Biomed Colorectal Cancer Screening Quest Diagnostics
BRIEF published on 11/29/2024 at 14:50, 1 year 2 months ago Mainz Biomed annonce un regroupement d'actions inversé pour améliorer sa conformité avec le Nasdaq Approbation Des Actionnaires Mayence Biomed Regroupement D'actions Prix Du Marché Conformité Au Nasdaq
BRIEF published on 11/29/2024 at 14:50, 1 year 2 months ago Mainz Biomed Announces Reverse Stock Split to Enhance Nasdaq Compliance Reverse Stock Split Shareholder Approval Nasdaq Compliance Market Price Mainz Biomed
PRESS RELEASE published on 11/29/2024 at 14:45, 1 year 2 months ago Mainz Biomed Announces Stock Split Mainz Biomed N.V. announces a 1-for-40 reverse stock split to comply with Nasdaq listing standards and increase investor appeal. Effective from December 3, 2024 Investors Nasdaq Mainz Biomed Molecular Genetics Stock Split
BRIEF published on 11/12/2024 at 15:05, 1 year 2 months ago Mainz Biomed collabore avec Thermo Fisher pour le développement d'un dépistage du cancer Mayence Biomed Dépistage Du Cancer Détection Colorectale Partenariat Avec Thermo Fisher Collaboration En Biotechnologie
BRIEF published on 11/12/2024 at 15:05, 1 year 2 months ago Mainz Biomed Collaborates with Thermo Fisher for Cancer Screening Development Cancer Screening Mainz Biomed Colorectal Detection Thermo Fisher Partnership Biotech Collaboration
PRESS RELEASE published on 11/12/2024 at 15:00, 1 year 2 months ago Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets Mainz Biomed and Thermo Fisher Scientific sign a collaboration agreement for the development of next generation colorectal cancer screening product for global markets Global Markets Thermo Fisher Scientific Mainz Biomed Collaboration Agreement Colorectal Cancer Screening
Published on 02/10/2026 at 12:00, 52 minutes ago Banyan Gold Strengthens Technical Team with Appointments of John Robins as Strategic Advisor and Key ESG Position
Published on 02/10/2026 at 09:01, 3 hours 51 minutes ago Star Copper to Deploy Advanced Deep-Penetrating 3D IP to Expedite 2026 Drill Program
Published on 02/10/2026 at 09:01, 3 hours 51 minutes ago Noram Fully Funded for 2026 and Engages GRE to Update PEA With Multiple High-Value Critical Mineral Byproduct Credits
Published on 02/10/2026 at 09:01, 3 hours 51 minutes ago Apex Mobilizes Second Drill Rig and Provides Phase I Update at the Rift Rare Earth Project in Nebraska, U.S.A.
Published on 02/10/2026 at 08:00, 4 hours 52 minutes ago Caledonia Mining Corporation Plc - Issue of Securities Pursuant to Long Term Incentive Plan Awards
Published on 02/10/2026 at 12:40, 12 minutes ago Qblox Announces Strategic Expansion of Executive Leadership Team
Published on 02/10/2026 at 12:05, 47 minutes ago IRBM Reports Breakthrough in Zika Virus Drug Discovery
Published on 02/10/2026 at 12:05, 47 minutes ago Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy in acute leukemias with limited treatment options
Published on 02/10/2026 at 11:55, 57 minutes ago Bybit Named Title Partner of Stockholm Open as Tournament Reclaims Historic identity
Published on 02/10/2026 at 11:35, 1 hour 17 minutes ago Maldives Launches Tech4Nature Project to Safeguard Iconic Whale Sharks
Published on 02/09/2026 at 18:00, 18 hours 52 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 19 hours 7 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 19 hours 7 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 19 hours 7 minutes ago Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 19 hours 7 minutes ago Déclaration des droits de vote à fin janvier 2026